Answers are grounded in this paper and cite their sources.
Reveals dual effects of ARX mutations on excitatory and inhibitory neurons, suggesting pathways for targeted therapies.
-driven mechanisms and represent a critical step toward developing targeted therapies for IS and related developmental epilepsies.
No takes yet. Share an insight, caveat, or question.
Nieto‐Estévez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: